Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective Cohort

• Main Authors: Saurav Verma (Author), Amanda Chapman (Author), Lee-Anne Pickard (Author), Danielle Porplycia (Author), Haley McConkey (Author), Patricia Jarosz (Author), James Sinfield (Author), Carolyn Lauzon-Young (Author), Matthew J Cecchini (Author), Christopher Howlett (Author), Natalie Grindrod (Author), Bekim Sadikovic (Author), Stephen A Welch (Author), Daniel Breadner (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: Human epidermal growth factor receptor-2 (HER2) is a well-established prognostic and predictive biomarker. It is an FDA-approved therapeutic target for HER2 positive breast, gastroesophageal, and more recently, lung and colon cancers. It is an emerging biomarker in biliary tract, bladder, cervi...